ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., R…
- Recall date
- April 10, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0395-2025
- FDA classification
- Class II
- Brand / firm
- ACCORD HEALTHCARE, INC.
- Sold / distributed
- Nationwide US.
Why it was recalled
Subpotent
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-448-17.
Get recall alerts
Free email alert whenever ACCORD HEALTHCARE, INC. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ACCORD HEALTHCARE, INC.